πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 200 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 9534041

Monoclonal antibodies that neutralize a norovirus

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9513287

High affinity monoclonal antibodies for detection of shiga toxin 2

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9499608

Bispecific monoclonal antibody therapeutics against West Nile virus with improved CNS pene

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9441050

High-affinity monoclonal anti-prion antibodies

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Sep 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 08 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9409994

High-affinity monoclonal antibodies to glypican-3 and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9409992

Mesothelin domain-specific monoclonal antibodies and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 04 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9394364

Human monoclonal antibodies specific for glypican-3 and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9371375

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic canc

PRECISION BIOLOGICS, INC. Β· Granted Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9310368

High affinity monoclonal antibodies for detection of Shiga toxin 2 (STX2)

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9303087

Monoclonal antibodies that inhibit the Wnt signaling pathway and methods of production and

The Board of Regents of the University of Oklahoma Β· Granted Tue Apr 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9279019

Human monoclonal antibodies specific for CD22

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Mar 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273136

Fully human anti-human NKG2D monoclonal antibodies

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273121

Humanized monoclonal antibodies that specifically bind and/or neutralize Japanese encephal

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9273124

Monoclonal antibodies that react with the capsule of Bacillus anthracis

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9206257

Human monoclonal antibodies specific for glypican-3 and use thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9181330

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

The Regents of the University of California Β· Granted Tue Nov 10 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9169326

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic canc

PRECISION BIOLOGICS, INC. Β· Granted Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9150644

Human monoclonal antibodies that bind insulin-like growth factor (IGF) I and II

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9127056

Monospecific and bispecific human monoclonal antibodies targeting insulin-like growth fact

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 08 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 03 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9097713

Monoclonal antibodies against glycoprotein of Ebola sudan boniface virus

THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY ON BEHALF OF USAMRMC Β· Granted Tue Aug 04 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9034588

Monoclonal antibody therapy for pancreas cancer

PRECISION BIOLOGICS, INC. Β· Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8999336

Monoclonal antibodies against Orthopoxviruses

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8961975

Monoclonal antibodies that neutralize anthrax toxins

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8956831

Nucleic acids encoding a human monoclonal antibody that specifically binds to IL-1Ξ±

XBIOTECH INC. Β· Granted Tue Feb 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 12 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted